Skip to main content
Log in

Genexpressionsprofile bei hormonrefraktären Prostatakarzinomen

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Yu YP, Landsittel D, Jing L et al. (2004) Gene Expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790–2799

    Article  PubMed  CAS  Google Scholar 

  2. Stoss O, Albers P, Werther M et al. (2007) Transcriptional profiling of transurethral resections provides insight into molecular mechanisms of hormone refractory prostate cancer. Prostate Cancer Prostate Dis (in press)

  3. Stoss O, Zielinski D, Czeloth K et al. (2007) Molecular analysis of hormone refractory prostate cancer supports the rationale of using mTOR inhibitors. ASCO Annual Meeting Proceedings, Part I, Vol 25, No 18. J Clin Oncol 25(Suppl): 21126

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Albers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoss, O., Jost, N., Czeloth, K. et al. Genexpressionsprofile bei hormonrefraktären Prostatakarzinomen. Urologe 46, 1117–1119 (2007). https://doi.org/10.1007/s00120-007-1447-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1447-x

Navigation